rethinkTHC Search
Menu
Study breakdown

Low-Dose Cannabinoid Supplement Improved Sleep Quality in a Small Crossover Trial

Clinical TrialPreliminary evidence
The takeaway

A cannabinoid supplement containing 3 mg THC, 6 mg CBN, and 10 mg CBD significantly improved sleep quality and insomnia symptoms compared to placebo in 20 adults with mild sleep problems.

Sleep medicine clinicians, adults with mild sleep problems, cannabinoid researchers

What the researchers found

In a double-blind crossover trial of 20 adults with subthreshold insomnia, a multi-cannabinoid oral supplement (3 mg THC, 6 mg CBN, 10 mg CBD, plus terpenes) significantly improved sleep quality/efficiency, insomnia symptoms, and health-related quality of life compared to placebo after 10 days. Mood and anxiety showed non-significant trends toward improvement. Anxiety improved significantly from baseline for the supplement group. No adverse events were reported.

Why it matters

This is one of the few controlled trials testing a low-dose multi-cannabinoid formulation specifically for sleep. The combination of THC, CBN, and CBD at low doses with a terpene blend may offer a more targeted approach than high-dose single-cannabinoid products.

The numbers in context

20 adults; mean age 47.4; 10-day treatment periods; 3 mg THC + 6 mg CBN + 10 mg CBD per softgel; significant improvements in sleep quality, insomnia symptoms, quality of life (p<0.05); no adverse events; non-significant mood improvements

How the study worked

Randomized, double-blind, placebo-controlled crossover pilot trial. 20 adults with subthreshold insomnia (mean age 47.4) completed 10 days in each condition with a 2-week washout. Validated questionnaires assessed sleep, mood, stress, pain, anxiety, fatigue, and quality of life.

What this study cannot tell us

Very small sample (N=20). Short treatment period (10 days). Self-reported sleep measures without objective polysomnography. Subthreshold insomnia only; may not apply to clinical insomnia. Washout adequacy not verified. Industry-funded study warrants independent replication.

How to read the evidence

Preliminary: very small pilot trial with short treatment duration and subjective outcomes only.

When this study was published

2025 publication

The bigger picture

Many cannabis users report using it for sleep, but controlled evidence is limited. Low-dose multi-cannabinoid formulations represent a growing product category that may be more appropriate for sleep than high-THC products.

Questions still open

  • Would these benefits persist with longer-term use?
  • Which cannabinoid component (THC, CBN, or CBD) drives the sleep benefit?

Read the original research

Effectiveness of a Cannabinoids Supplement on Sleep and Mood in Adults With Subthreshold Insomnia: A Randomized Double-Blind Placebo-Controlled Crossover Pilot Trial.

Health science reports, 8(2), e70481

Citation

Hausenblas, Heather; Hooper, Stephanie; Lynch, Tarah. (2025). Effectiveness of a Cannabinoids Supplement on Sleep and Mood in Adults With Subthreshold Insomnia: A Randomized Double-Blind Placebo-Controlled Crossover Pilot Trial.. Health science reports, 8(2), e70481. https://doi.org/10.1002/hsr2.70481

Explore the wider topic